We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pluristem Therapeutics Inc | NASDAQ:PSTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.00 | 0.99 | 1.05 | 0 | 01:00:00 |
Nevada
|
001-31392
|
|
98-0351734
|
(State or Other Jurisdiction
of Incorporation) |
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
MATAM Advanced Technology Park
Building No. 5
Haifa, Israel
|
|
3508409
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.00001 per share
|
PSTI
|
The Nasdaq Capital Market
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Director Name
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
||||||||||||
Zami Aberman
|
47,932,806
|
5,998,887
|
946,890
|
30,292,175
|
||||||||||||
Israel Ben-Yoram
|
49,242,584
|
4,523,344
|
1,112,655
|
30,292,175
|
||||||||||||
Isaac Braun
|
48,654,852
|
5,090,742
|
1,132,989
|
30,292,175
|
||||||||||||
Mark Germain
|
49,700,202
|
3,602,989
|
1,575,392
|
30,292,175
|
||||||||||||
Moria Kwiat
|
48,636,344
|
5,109,193
|
1,133,046
|
30,292,175
|
||||||||||||
Hava Meretzki
|
47,640,257
|
6,098,227
|
1,140,099
|
30,292,175
|
||||||||||||
Nachum Rosman
|
49,188,398
|
4,588,936
|
1,101,249
|
30,292,175
|
||||||||||||
Doron Shorrer
|
50,257,140
|
3,523,859
|
1,097,584
|
30,292,175
|
||||||||||||
Yaky Yanay
|
47,835,268
|
6,158,000
|
885,315
|
30,292,175
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
82,305,134
|
1,123,545
|
1,742,079
|
N/A
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
75,319,683
|
9,295,192
|
555,882
|
N/A
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
37,523,789
|
16,559,609
|
795,185
|
30,292,175
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
38,869,479
|
15,209,038
|
800,066
|
30,292,175
|
1 Year
|
2 Years
|
3 Years
|
Abstain
|
Broker Non-Votes
|
17,974,548
|
34,364,111
|
559,966
|
1,979,958
|
30,292,175
|
|
PLURISTEM THERAPEUTICS INC.
|
|
|
|
|
Date: June 13, 2019
|
By:
|
/s/ Chen Franco-Yehuda
|
|
Name:
|
Chen Franco-Yehuda
|
|
Title:
|
Chief Financial Officer
|
1 Year Pluristem Therapeutics Chart |
1 Month Pluristem Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions